How to lower cholesterol ― Five facts and misunderstandings - The Korea Herald

How to lower cholesterol ― Five facts and misunderstandings The Korea Herald Aren't there any secrets to lower cholesterol? 1. What is the difference between “good” cholesterol and “bad?” Many people still ask me this question. The answer is very easy. “Bad” cholesterol (LDL cholesterol) is the more important of the two. and more »

US Appeals Court Upholds Dismissal Of Some AstraZeneca Crestor Patent Suits - Fox Business

US Appeals Court Upholds Dismissal Of Some AstraZeneca Crestor Patent Suits Fox Business A US appeals court upheld a lower court's dismissal of certain AstraZeneca PLC (AZN) patent-infringement lawsuits against several generic manufacturers that are planning to sell copies of the company's blockbuster cholesterol-lowering drug Crestor. AstraZeneca Pharmaceuticals LP v. Apotex Corp. (Fed. Cir. 2012)Patent Docs AstraZeneca Loses Ruling Over 2018 and 2021 Crestor PatentsBloomberg all 7 news articles »

Teen weight loss program shows some benefit - Reuters

Teen weight loss program shows some benefit Reuters The kids had lower cholesterol and triglyceride levels at the end of the year as well as higher scores on measures of self worth, academic and athletic abilities, and social acceptance. On average, the kids actually gained weight -- which isn't ... and more »

New cholesterol procedure is 'major game changer' - KBOI-TV

New cholesterol procedure is 'major game changer' KBOI-TV Medications themselves in addition to diet changes are not enough to lower these levels, and this is where this procedure is very helpful." Ideal levels for LDL cholesterol are under 100. But patients on the Saint Alphonsus apheresis program are higher ...

WellPoint to Cease Branded Lipitor Coverage, Favor Generics - Wall Street Journal

WellPoint to Cease Branded Lipitor Coverage, Favor Generics Wall Street Journal By JON KAMP Health-insurer WellPoint Inc. is planning to stop covering Pfizer Inc.'s Lipitor cholesterol-lowering pills for millions of members in favor of generic versions, marking a new challenge to Pfizer's efforts to fend off generic competition to ... and more »